“…Both nicdicaments occupy the same binding sites on albumin (17, 14, 29, 83, 98), which results in competitive displacenient reactions and in increasing the concentration of free, active tolbutaniid in the blood (23). Conversely in the test of albuniiri-bound bromsulphalein (ESP), tolbutamide accelerates the disappearance of the dye from the blood in the liver, and can therefore in liver tests lead to incorrect diagnosis (38,39). I n addition to this though, tolbutaniide can, through a similar substitution, sink a pathologically in-the endogenous cortisole from its binding to the albumins.…”